Among the top markers is kallistatin, and we have previously reported that kallistatin levels increased following an 8-week intensive phase of TB therapy (23), which is consistent with our findings here of lower kallistatin levels in TB compared to non-TB serum. Here, SERPINA4 is linked to tuberculosis.